Free Trial

Myriad Genetics (MYGN) Short Interest Ratio & Short Volume

Myriad Genetics logo
$17.83
-0.16 (-0.89%)
(As of 11/4/2024 ET)

Myriad Genetics Short Interest Data

Myriad Genetics (MYGN) has a short interest of 4.49 million shares. This marks a 7.16% increase in short interest from the previous month. The short interest ratio (days to cover) is 6.4, indicating that it would take 6.4 days of the average trading volume of 723,805 shares to cover all short positions.

Current Short Interest
4,490,000 shares
Previous Short Interest
4,190,000 shares
Change Vs. Previous Month
+7.16%
Dollar Volume Sold Short
$107.67 million
Short Interest Ratio
6.4 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
90,820,000 shares
Percentage of Shares Shorted
4.94%
Today's Trading Volume
1,846,427 shares
Average Trading Volume
723,805 shares
Today's Volume Vs. Average
255%
Short Selling Myriad Genetics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Myriad Genetics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MYGN Short Interest Over Time

MYGN Days to Cover Over Time

MYGN Percentage of Float Shorted Over Time

Myriad Genetics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/20244,490,000 shares $107.67 million +7.2%N/A6.4 $23.98
9/30/20244,190,000 shares $114.76 million +6.4%N/A5.7 $27.39
9/15/20243,940,000 shares $108.70 million No ChangeN/A5 $27.59
8/31/20243,940,000 shares $111.62 million +1.6%N/A5 $28.33
8/15/20243,880,000 shares $108.06 million -11.6%N/A5.1 $27.85
7/31/20244,390,000 shares $122.79 million +14.3%N/A5.1 $27.97
7/15/20243,840,000 shares $102.30 million -16.7%N/A4.7 $26.64
6/30/20244,610,000 shares $112.76 million -24.3%N/A5.9 $24.46
6/15/20246,090,000 shares $141.29 million +26.6%N/A8.1 $23.20
5/31/20244,810,000 shares $109.48 million -5.7%N/A6.7 $22.76
5/15/20245,100,000 shares $125.77 million -14.3%N/A6.9 $24.66
4/30/20245,950,000 shares $116.44 million +8.2%N/A8.6 $19.57
4/15/20245,500,000 shares $105.44 million -3.0%N/A9 $19.17
3/31/20245,670,000 shares $120.88 million +18.1%N/A8.9 $21.32
3/15/20244,800,000 shares $101.57 million +20.0%N/A7.5 $21.16
2/29/20244,000,000 shares $83.72 million +8.1%N/A6 $20.93
2/15/20243,700,000 shares $87.28 million -0.3%N/A5.8 $23.59
1/31/20243,710,000 shares $79.36 million -2.9%N/A5.4 $21.39
1/15/20243,820,000 shares $75.90 million -10.3%6.0%5.4 $19.87
12/31/20234,260,000 shares $81.54 million -14.8%N/A6.4 $19.14
12/15/20235,000,000 shares $103.70 million +4.4%N/A7.4 $20.74
11/30/20234,790,000 shares $91.44 million -2.2%N/A7.4 $19.09
11/15/20234,900,000 shares $85.36 million -14.8%N/A8 $17.42
10/31/20235,750,000 shares $89.59 million +4.0%N/A10.4 $15.58
10/15/20235,530,000 shares $80.41 million +11.9%N/A10.6 $14.54
9/30/20234,940,000 shares $79.24 million +1.7%N/A9.5 $16.04
9/15/20234,860,000 shares $80.72 million +9.0%N/A9.7 $16.61
8/31/20234,460,000 shares $79.61 million +15.0%N/A9.2 $17.85
8/15/20233,880,000 shares $68.60 million -2.8%N/A7.5 $17.68
7/31/20233,990,000 shares $89.18 million -5.5%N/A7.6 $22.35
7/15/20234,220,000 shares $94.95 million +3.9%N/A8 $22.50
6/30/20234,060,000 shares $94.11 million -0.5%N/A7.3 $23.18
6/15/20234,080,000 shares $93.60 million -3.3%N/A7.3 $22.94
5/31/20234,220,000 shares $93.09 million +11.9%N/A7.2 $22.06
5/15/20233,770,000 shares $70.95 million +2.5%N/A6.1 $18.82
4/30/20233,680,000 shares $78.35 million -1.6%N/A6 $21.29
4/15/20233,740,000 shares $83.29 million -25.9%N/A6.2 $22.27
3/31/20235,050,000 shares $117.31 million -2.7%N/A8.4 $23.23
3/15/20235,190,000 shares $121.08 million +15.9%N/A7.4 $23.33
2/28/20234,480,000 shares $84.76 million +10.6%N/A6.1 $18.92
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

2/15/20234,050,000 shares $77.96 million +22.7%N/A5.9 $19.25
1/31/20233,300,000 shares $65.08 million +2.8%N/A4.6 $19.72
1/15/20233,210,000 shares $59.93 million -9.6%N/A4.3 $18.67
12/30/20223,550,000 shares $51.51 million -8.3%N/A4.8 $14.51
12/15/20223,870,000 shares $65.52 million +13.5%N/A5.9 $16.93
11/30/20223,410,000 shares $69.09 million -16.0%N/A6 $20.26
11/15/20224,060,000 shares $84.77 million +5.5%N/A7.4 $20.88
10/31/20223,850,000 shares $79.85 million +1.1%N/A7.3 $20.74
10/15/20223,810,000 shares $71.21 million +0.8%N/A7.7 $18.69
9/30/20223,780,000 shares $72.12 million -3.8%N/A7.3 $19.08
9/15/20223,930,000 shares $84.57 million +1.6%N/A7.7 $21.52
8/31/20223,870,000 shares $86.46 million -7.9%N/A7.3 $22.34
8/15/20224,200,000 shares $117.10 million +15.4%N/A7.7 $27.88
7/31/20223,640,000 shares $96.02 million -16.3%4.7%6.3 $26.38
7/15/20224,350,000 shares $95.61 million +23.6%5.7%7.7 $21.98
6/30/20223,520,000 shares $63.96 million -4.1%4.6%6.6 $18.17
6/15/20223,670,000 shares $61.77 million +0.3%4.8%6.8 $16.83
5/31/20223,660,000 shares $70.42 million -5.2%4.8%6.5 $19.24
5/15/20223,860,000 shares $86.35 million +14.2%5.0%6.9 $22.37
4/30/20223,380,000 shares $69.29 million +1.2%4.4%6.4 $20.50
4/15/20223,340,000 shares $80.09 million -7.5%4.4%6.4 $23.98
3/31/20223,610,000 shares $90.97 million -10.4%4.7%6.6 $25.20
3/15/20224,030,000 shares $96.88 million -2.7%5.3%7.4 $24.04
2/28/20224,140,000 shares $100.93 million +0.2%5.4%7.4 $24.38
2/15/20224,130,000 shares $112.13 million -4.0%5.4%7.5 $27.15
1/31/20224,300,000 shares $113.05 million +12.0%5.6%7.6 $26.29
1/15/20223,840,000 shares $106.71 million +6.1%5.0%6.7 $27.79
12/31/20213,620,000 shares $99.91 million -9.1%4.7%7 $27.60
12/15/20213,980,000 shares $107.46 million -2.7%5.2%7.9 $27.00
11/30/20214,090,000 shares $105.77 million +5.7%5.3%9.5 $25.86
11/15/20213,870,000 shares $114.51 million -9.2%5.0%9 $29.59
10/29/20214,260,000 shares $131.08 million -8.8%5.5%10.4 $30.77
10/15/20214,670,000 shares $148.23 million -1.5%6.2%10.9 $31.74
9/30/20214,740,000 shares $153.05 million -2.9%6.3%9.6 $32.29
9/15/20214,880,000 shares $159.67 million -7.8%6.4%8.6 $32.72
8/31/20215,290,000 shares $189.28 million -5.0%7.0%9.1 $35.78
8/13/20215,570,000 shares $182.64 million -4.6%7.4%9.6 $32.79
7/30/20215,840,000 shares $184.72 million -7.5%7.8%9.8 $31.63
7/15/20216,310,000 shares $197.25 million +18.4%8.4%11 $31.26
6/30/20215,330,000 shares $162.99 million -0.7%7.1%9.4 $30.58
6/15/20215,370,000 shares $160.89 million -0.4%7.2%9.8 $29.96
5/28/20215,390,000 shares $154.42 million -5.3%7.2%9.5 $28.65
5/14/20215,690,000 shares $145.95 million +3.3%N/A9.4 $25.65
4/30/20215,510,000 shares $166.57 million +1.9%N/A8.4 $30.23
4/15/20215,410,000 shares $151.16 million +4.4%N/A7.5 $27.94
3/31/20215,180,000 shares $151.05 million +2.8%7.1%6.5 $29.16
3/15/20215,040,000 shares $156.44 million +0.2%6.9%6.1 $31.04
2/26/20215,030,000 shares $151.96 million -0.2%7.0%5.8 $30.21
2/12/20215,040,000 shares $151.91 million -24.1%7.0%6 $30.14
1/29/20216,640,000 shares $183.53 million -14.5%9.2%7.7 $27.64
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

1/15/20217,770,000 shares $200.47 million -14.6%10.8%9.9 $25.80
12/31/20209,100,000 shares $178.63 million -5.9%12.6%12.1 $19.63
12/15/20209,670,000 shares $178.70 million -1.1%13.4%14.6 $18.48
11/30/20209,780,000 shares $173.89 million -1.3%13.5%15.6 $17.78
11/15/20209,910,000 shares $165.99 million +3.9%13.7%15.6 $16.75
10/30/20209,540,000 shares $124.69 million +3.6%13.2%13.3 $13.07
10/15/20209,210,000 shares $111.99 million -1.8%12.8%12.9 $12.16
9/30/20209,380,000 shares $122.32 million -11.0%13.1%12.5 $13.04
9/15/202010,540,000 shares $139.23 million -1.8%14.6%12.1 $13.21
8/31/202010,730,000 shares $143.46 million +0.5%14.9%10.1 $13.37
8/14/202010,680,000 shares $135.21 million -1.5%14.8%9.1 $12.66
7/31/202010,840,000 shares $130.84 million -1.5%15.0%9.7 $12.07
7/15/202011,000,000 shares $130.35 million +0.6%15.2%8.9 $11.85
6/30/202010,930,000 shares $120.45 million +22.7%15.1%8.9 $11.02
6/15/20208,910,000 shares $113.25 million +20.2%12.3%7.5 $12.71
5/29/20207,410,000 shares $106.78 million +0.3%10.3%6.7 $14.41
5/15/20207,390,000 shares $108.85 million -15.5%10.2%6.9 $14.73
4/30/20208,750,000 shares $137.64 million -7.0%12.1%7.1 $15.73
4/15/20209,410,000 shares $135.50 million +1.8%13.0%8.3 $14.40
3/31/20209,240,000 shares $134.07 million -21.5%12.8%8.1 $14.51
3/13/202011,772,600 shares $179.53 million -7.0%16.3%10.5 $15.25
2/28/202012,660,000 shares $156.73 million -0.9%17.5%12.3 $12.38
2/14/202012,770,000 shares $195.64 million +8.2%17.7%13.2 $15.32
1/31/202011,800,000 shares $211.57 million -8.0%16.3%12.2 $17.93
1/15/202012,820,000 shares $252.81 million -6.2%17.8%12.5 $19.72
12/31/201913,670,000 shares $391.24 million +32.1%18.9%13.8 $28.62

MYGN Short Interest - Frequently Asked Questions

What is Myriad Genetics' current short interest?

Short interest is the volume of Myriad Genetics shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 4,490,000 shares of MYGN short. Learn More on Myriad Genetics' current short interest.

What is a good short interest ratio for Myriad Genetics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MYGN shares currently have a short interest ratio of 6.0. Learn More on Myriad Genetics's short interest ratio.

Which institutional investors are shorting Myriad Genetics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Myriad Genetics: Concourse Financial Group Securities Inc., and Millennium Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Myriad Genetics' short interest increasing or decreasing?

Myriad Genetics saw a increase in short interest in October. As of October 15th, there was short interest totaling 4,490,000 shares, an increase of 7.2% from the previous total of 4,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Myriad Genetics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Myriad Genetics: Intellia Therapeutics, Inc. (16.11%), QuidelOrtho Co. (6.29%), Neogen Co. (10.68%), Repligen Co. (6.64%), Halozyme Therapeutics, Inc. (8.32%), Ionis Pharmaceuticals, Inc. (6.78%), Madrigal Pharmaceuticals, Inc. (18.65%), Alkermes plc (9.78%), Amicus Therapeutics, Inc. (7.40%), Geron Co. (13.08%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Myriad Genetics stock?

Short selling MYGN is an investing strategy that aims to generate trading profit from Myriad Genetics as its price is falling. MYGN shares are trading down $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Myriad Genetics?

A short squeeze for Myriad Genetics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MYGN, which in turn drives the price of the stock up even further.

How often is Myriad Genetics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MYGN, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:MYGN) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners